19th Clinical Trials on Alzheimer's Disease (CTAD) 2026
Talk
Biotech Showcase (Late Breaking)
Wed, Nov 18, 2026 · 5:00–5:20 PM EST Ballroom - 4th floor, Boston Marriott Copley Place
About this session
Late-breaking biotech showcase talks: (4) A First-in-Class CNS-Penetrant Small Molecule Targeting APOE4-mediated Neurovascular Dysfunction in Alzheimer's Disease; (5) Temporal Biodynamics: An AI Platform for Identification of Stage-Relevant Targets and Biomarkers; (6) Multimodal AI for early prediction and precision stratification in ADRD.
Speakers
-
Alzheimer's Drug Discovery Foundation
Chair
-
Global BHP Braintrust
Chair